BioMarin Pharmaceutical Inc.
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionEdgewood Management Llc
Latest Disclosed Ownership10,000 shares
Latest Disclosed Value $ 564,900
Edgewood Management Llc ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 14, 2026 - Edgewood Management Llc filed a 13F-HR form disclosing ownership of 10,000 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $564,900 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 0 shares of BioMarin Pharmaceutical Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,000 10,000 565 0.0036
2026-02-12 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -15,000 -100.00 0 -100.00
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 812 -1.46 0.0029
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 825 -22.26 0.0026
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,060 7.61 0.0037
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 986 -6.55 0.0028
2024-11-12 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,054 -14.59 0.0028
2024-08-13 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,235 -5.80 0.0033
2024-05-14 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,310 -9.41 0.0035
2024-02-13 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,446 8.97 0.0042
2023-11-13 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,327 2.08 0.0043
2023-08-11 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,300 -10.84 0.0039
2023-05-12 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,459 -6.06 0.0047
2023-02-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,552 22.01 0.0055
2022-11-10 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,272 2.33 0.0044
2022-08-12 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,243 7.53 0.0037
2022-05-11 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,156 -12.75 0.0023
2022-02-11 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,325 14.32 0.0022
2021-11-12 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,159 -7.43 0.0019
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,252 10.50 0.0021
2021-05-13 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 0 0.00 1,133 -13.84 0.0022
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,000 5,000 50.00 1,315 72.80 0.0026
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,000 5,000 100.00 761 23.34 0.0017
2020-08-12 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,000 0 0.00 617 46.21 0.0015
2020-05-13 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,000 0 0.00 422 -0.24 0.0014
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,000 5,000 423 0.0013
2017-02-10 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -11,030 -100.00 0 -100.00
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,030 6,030 120.60 1,020 162.21 0.0067
2016-08-11 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,000 0 0.00 389 -5.58 0.0029
2016-05-09 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,000 0 0.00 412 -21.37 0.0030
2016-02-10 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,000 0 0.00 524 -0.57 0.0039
2015-11-10 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,000 0 0.00 527 -22.95 0.0045
2015-08-07 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,000 0 0.00 684 9.79 0.0057
2015-05-06 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,000 5,000 623 0.0056
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.